InnoSIGN
Eindhoven
About InnoSIGN
InnoSIGN is an mRNA-based pathway activity profiling technique that aims to transform precision medicine by providing greater insight into disease causes. The company proposes to use its enormous library of pathway activity profiles to enhance diagnostics and drug discovery, giving researchers with qPCR tests for decentralized use through a service testing facility in the Netherlands.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: innosignbio.com
- Phone: +31 40 273 01 55
Industries & Categories
Biotechnology, Life Science, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/innosign-70547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.